July 2007
ICIS Chemical Business;7/2/2007, Vol. 2 Issue 73, p10
Trade Publication
The article speculates whether Len Blavatnik, owner of Basell Corp., will acquire Lyondell Chemical Co. After missing an opportunity to acquire GE Plastics, Blavatnik is believed to have set his eyes on Lyondell's acquisition. It is reported that Lyondell shares fell on the news that Huntsman, not Lyondell, had been bought by Basell Corp.


Related Articles

  • LEN BLAVATNIK. Chang, Joe // ICIS Chemical Business;12/3/2007, Vol. 272 Issue 21, p13 

    The article offers information on the business strategies of Len Blavatnik, founder of Access Industries Inc., in expanding its sales and services worldwide. Blavatnik acquired Lyondell Chemical Co. for $19 billion and bought the European polyolefins giant Basell Corp. in 2005. The acquisition...

  • Untitled.  // ICIS Chemical Business;7/30/2007, Vol. 272 Issue 5, p33 

    The article comments on current merger and acquisition deals in the chemical industry. Values of the deals, as stated, are currently high and have opened up new opportunities for sellers. Basell's owner Len Blavatnik is estimated to be paying $19 billion, 11 times normalized earnings before...

  • Lyondell/Basell poised for top five position. Bains, Elizabeth; Baker, John; Gibson, Jane // ICIS Chemical Business;5/21/2007, Vol. 2 Issue 67, p4 

    The article reports on the plans of Russian billionaire Leonard Blavatnik for Lyondell Chemical and Basell. Blavatnik is considering taking over Lyondell Chemical and merging it with Basell. If Blavatnik pulls off both deals, he could create a global top five chemicals producer. Blavatnik has...

  • Is anyone safe from predators? Baker, John; Gibson, Jane // ICIS Chemical Business;5/21/2007, Vol. 2 Issue 67, p5 

    The authors reflect on the merger activities happening within the chemical industry. The authors mentioned several merger and acquisition deals including the plans of Russian billionaire Len Blavatnik to acquire Lyondell Chemical and GE Plastics and the sale of Organon pharma and animal health...

  • The ones toThe ones to. Chang, Joseph // ICIS Chemical Business;9/17/2007, Vol. 272 Issue 10, p30 

    The article reports on the increasing consolidation activity in the chemical industry. According to New York-based investment bank Young & Partners, the global chemical industry has completed $15billion in consolidation deals during the first half of 2007. Saudi Arabia's SABIC has acquired...

  • A cool $19bn is a good deal. Davis, Nigel // ICIS Chemical Business;7/23/2007, Vol. 272 Issue 4, p10 

    The article focuses on acquisition of Lyondell Chemical Co. by Basell Corp. It reports on advantages enjoyed by Basell after acquisition by paying a premium of $19 billion. It provides Basell with upstream integration in the U.S. and new polyethylene (PE) production capacity. An overview of...

  • M&A in the Middle? Westervelt, Roberts // Chemical Week;11/7/2007, Vol. 169 Issue 36, p3 

    The author looks at the merger and acquisition (M&A) activity in the chemical industry. He states that M&A activity has slowed in the chemical market due to a credit crunch and the reluctance by banks to fund further big deals. He cites the planned acquisition of Lyondell Chemical by Basell, as...

  • newsbriefs.  // Chemical Week;1/7/2008, Vol. 170 Issue 1, p4 

    This section offers world news briefs on the chemical industry. Basell completed its acquisition of Lyondell Chemical and will rename the combined company, LyondellBasell Industries. State-owned oil company Ecopetrol agreed to purchase Propilco, the largest producer of polypropylene (PP) resins...

  • Basell and Lyondell to Take New Name After Merger. Phillips, Kate // Chemical Week;11/7/2007, Vol. 169 Issue 36, p7 

    The article focuses on the proposed merger of Basell and Lyondell Chemical. Basell and Lyondell Chemical will be renamed LyondellBasell Industries, following completion of their proposed merger. Basell agreed to acquire Lyondell in July 2007 for $12.7 billion in an all-cash transaction. The deal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics